论文部分内容阅读
Circulating tumor cells(CTCs) arise from primary or secondary tumors and enter the bloodstream by active or passive intravasation.Given the low number of CTCs,enrichment is necessary for detection.Filtration methods are based on selection of CTCs by size using a filter with 6.5 to 8 μm pores.After coloration,collected CTCs are evaluated according to morphological criteria.Immunophenotyping and fluorescence in situ hybridization techniques may be used.Selected CTCs can also be cultivated in vitro to provide more material.Analysis of genomic mutations is difficult because it requires adapted techniques due to limited DNA materials.Filtration-selected CTCs have shown prognostic value in many studies but multicentric validating trials are mandatory to strengthen this assessment.Other clinical applications are promising such as follow-up,therapy response prediction and diagnosis.Microfluidic emerging systems could optimize filtration-selected CTCs by increasing selection accuracy.
Circulating tumor cells (CTCs) arise from primary or secondary tumors and enter the bloodstream by active or passive intravasation. Gain the low number of CTCs, enrichment is necessary for detection. Filtration methods are based on selection of CTCs by size using a filter with 6.5 to 8 μm pores. After coloration, collected CTCs are evaluated according to morphological criteria. Immunophenotyping and fluorescence in situ hybridization techniques may be used. Selected CTCs can also be cultivated in vitro to provide more material. Analysis of genomic mutations is difficult because it requires adapted techniques due to limited many materials but more importantly limited to DNA materials. Filtration-selected CTCs have shown prognostic value in many studies but multicentric validating trials are mandatory to strengthen this assessment. Other clinical applications are promising such as follow-up, therapy response prediction and diagnosis. Microfluidic emerging systems could optimize filtration-selected CTCs by increasing selection accuracy.